EAACI Congress 2024
BackL-FT 01 - Flash talks on Asthma
Friday 31 May, 12:00 PM -
13:00 PM Valencia, Spain
Cordoba
Flash Talks
12:00
Mucosal vaccine MV130 impairs eosinophilic allergic airway inflammation by restoring local and systemic healthy innate and adaptive immune responses
12:07
Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study
12:14
Impact of the implementation of recommendations from the Medical Indoor Environment Counselor (MIEC) on the health evolution of patients allergic to dust mites
12:21
Establishing Normal Reproducibility Ranges for Spirometry Measures in Healthy Children: Insights from a Longitudinal Cohort Study
12:28
Dupilumab Effect on Exacerbations and Lung Function Despite Withdrawal of Inhaled Corticosteroids/Long-acting Beta Agonists
12:35
Maternal Atopy May Be A Risk Factor For Pulmonary Airway Resistance In Wheezy Children
12:42
Monitoring Patients with Severe Eosinophilic Asthma Receiving Benralizumab in Allergy Centers in Greece for 8-12 months - REALISM-A Study (gReek rEAl Life regIStry of benralizuMab among Allergists)
